Search Results for: cancer

By Kuldip K. Ambastha On Thursday, January 5, 2023, the stock of NovoCure Limited (NVCR), an oncology company, rose by +68.5% for the trading day. The LUNAR study has shown that a medical device developed by NovoCure is able to improve, in a statistically significant way, the prospect of survival for people with late-stage lung …

Continue reading “What Caught Our Attention in the Investment World? – Week of January 3-6, 2023”

By Kuldip K. Ambastha The stock of BeiGene, Ltd. (BGNE), a commercial stage biopharmaceutical company focused on cancer treatment drugs, saw a +20.5% increase in price per share on Wednesday, October 12, 2022. Brukinsa (zanubrutinib) in its Phase 3 trial data showed highly positive results in people with chronic lymphocytic leukemia (CLL) or small lymphocytic …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 10-14, 2022”

By Kuldip K. Ambastha The stock price of Sotera Health Company (SHC), an integrated global health solutions company, had a loss of -33.3% per share on Monday, September 19, 2022. On the subsequent trading days of the week, three negative daily returns and one positive daily return were seen. Litigation was the primary cause of …

Continue reading “What Caught Our Attention in the Investment World? – Week of September 19-23, 2022”

By Kuldip K. Ambastha BioNTech SE (BNTX) is aiming to become a leading biotechnology company with a main focus on individualized cancer medicine. The company has also been successful in offering an mRNA-based, two-shot coronavirus vaccine called BNT162b2 (aka: Comirnaty and Tozinameran), which has become increasingly important due to the rise of the highly contagious …

Continue reading “What Caught Our Attention in the Investment World? – Week of August 9-13, 2021”

By Kuldip K. Ambastha On Friday, July 16, 2021, the stock of Moderna, Inc. (MRNA) was up by +10.3% for the trading day. Moderna, a biotechnology company, has been highly successful in its efforts to develop a coronavirus (COVID-19) vaccine. Late on Thursday, July 15, 2021, S&P Dow Jones Indices announced that Moderna will become …

Continue reading “What Caught Our Attention in the Investment World? – Week of July 12-16, 2021”

By Kuldip K. Ambastha and Anil K. Ambastha On Monday, December 9, 2019, big news emerged in the mergers & acquisitions field in terms of Merck & Co., Inc. (MRK) buying ArQule, Inc. (ARQL) and Sanofi SA (SNY) buying Synthorx Inc. (THOR). Both Merck and Sanofi bought the smaller companies to enhance their capabilities in …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 9-13, 2019”